A phase I study of bi-weekly carboplatin/paclitaxel chemotherapy in elderly advanced non-small cell lung cancer
Phase 1
- Conditions
- on-small-cell lung cancer
- Registration Number
- JPRN-UMIN000005263
- Lead Sponsor
- Shimane University Faculty of Medicine, Division of Clinical Oncology and Respiratory Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
Not provided
Exclusion Criteria
1)Previous 2-regimen chemotherapy or 1-regimen of EGFR-TKI 2)Concurrent chemoradiotherapy 3)Serious infections 4)Ssymptomatic brain metastasis 5)Massive pericardial, pleural effusion, or ascites 6)Serious clinical probrems 7)Previous drug allergy or alchol allergy 8)Hoped to be pregnant/ nursing 9)Those judged to be not suitable by the attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maximum Tolerated Dose of CBDCA+PTX bi-weekly therapy
- Secondary Outcome Measures
Name Time Method Anti tumor efficacy, Quality of life